"10.1371_journal.pone.0054461","plos one","2013-01-25T00:00:00Z","Jacques Amar; Céline Lange; Gaëlle Payros; Celine Garret; Chantal Chabo; Olivier Lantieri; Michael Courtney; Michel Marre; Marie Aline Charles; Beverley Balkau; Rémy Burcelin; D.E.S.I.R. Study Group","INSERM U1048, Institute of Research on Metabolic and Cardiovascular Diseases, CHU Toulouse, Toulouse, France; INSERM, CESP Centre for research in Epidemiology and Population Health, U1018, Epidemiology of Diabetes, Obesity and Chronic Kidney Disease Over the Lifecourse, Villejuif, France; University Paris Sud 11, UMRS 1018, Villejuif, France; Bio-Medical Research Federative Institute of Toulouse, Toulouse, France; IRSA, La Riche, France; VAIOMER SAS, Toulouse, France; Service d'endocrinologie-diabète-nutrition, Groupe Hospitalier Bichat-Claude Bernard, Assistance Publique des Hôpitaux de Paris, Paris, France; INSERM U695, Université Denis Diderot Paris 7, Paris, France","Conceived and designed the experiments: JA RB BB. Performed the experiments: CL GP CG CC . Analyzed the data: OL MM MC MAC. Wrote the paper: JA CL RB MM BB.","The authors received funding from commercial sources: Lilly, Novartis Pharma and Sanofi-Aventis, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Santé, Novo Nordisk, Pierre Fabre, Roche, Topcon. The authors also declare that Remy Burcelin, Chantal Chabo, Beverley Balkau and Jacques Amar are listed as coinventors on patents held by the National Institute for Health and Medical Research (INSERM) that relate to the use of bacterial DNA in metabolic diseases. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","01","Jacques Amar","JA",12,TRUE,3,5,4,5,TRUE,FALSE,FALSE,0,NA,FALSE
